Dobutamine and Propranolol Interaction
Drug interaction information between Dobutamine and Propranolol.
Dobutamine and Propranolol have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Dobutamine and Propranolol. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Propranolol blocks the same receptors that dobutamine tries to activate, which stops dobutamine from working correctly. This can also make heart stress tests less accurate because the heart does not respond to the medicine as expected.
What To Do
Your doctor may need to adjust your medication or account for reduced test sensitivity if you are undergoing a heart stress test.
FDA Label Information
Isoproterenol and Dobutamine Propranolol is a competitive inhibitor of beta-receptor agonists, and its effects can be reversed by administration of such agents, e.g., dobutamine or isoproterenol. Also, propranolol may reduce sensitivity to dobutamine stress echocardiography in patients undergoing evaluation for myocardial ischemia.
Dobutamine Also Interacts With
- Carbidopa/Levodopa moderate
- Atomoxetine minor
Frequently Asked Questions
Can I take Dobutamine and Propranolol together?
This is a minor interaction. Your doctor may need to adjust your medication or account for reduced test sensitivity if you are undergoing a heart stress test.
How serious is the interaction between Dobutamine and Propranolol?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Dobutamine and Propranolol interact?
Propranolol blocks the same receptors that dobutamine tries to activate, which stops dobutamine from working correctly. This can also make heart stress tests less accurate because the heart does not respond to the medicine as expected.
Understanding the Dobutamine and Propranolol Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Dobutamine belongs to the Inotropic Agent (Beta-1 Agonist) class and Propranolol belongs to the Non-Selective Beta-Blocker class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Propranolol blocks the same receptors that dobutamine tries to activate, which stops dobutamine from working correctly. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Dobutamine has 3 total documented interactions on file in this dataset, and Propranolol has 44. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to adjust your medication or account for reduced test sensitivity if you are undergoing a heart stress test. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Dobutamine or Propranolol based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.